Compile Data Set for Download or QSAR
maximum 50k data
Found 98 Enz. Inhib. hit(s) with all data for entry = 10372
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426698(N-(3-(6-phenyl-2-(phenylamino)quinazolin- 8-yl)phe...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426700(N-(3-(2-(phenylamino)-6-(pyridin-3- yl)quinazolin-...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426679(N-(3-(6-phenylquinazolin-8-yl)phenyl)acrylamide | ...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426684(N-(3-(6-(2-chlorophenyl)quinazolin-8- yl)phenyl)ac...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426697(N-(3-(6-(3-fluorophenyl)quinazolin-8- yl)phenyl)ac...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM531226(US11208388, Example 8)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM531227(US11208388, Example 13)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM531228(US11208388, Example 23)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM531229(US11208388, Example 28)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426690(4-(8-(3-acrylamidophenyl)quinazolin-6-yl)- N-(3-(t...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM531231(US11208388, Example 38)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426680(N-(3-(2-amino-6-phenylquinazolin-8- yl)phenyl)acry...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM531234(US11208388, Example 51)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM531235(US11208388, Example 52)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426686(1-(3-(2-amino-6-(4-phenoxyphenyl)quinazolin- 8-yl)...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM531238(US11208388, Example 61)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM531239(US11208388, Example 64)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM531240(US11208388, Example 65)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM531241(US11208388, Example 67)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM531242(US11208388, Example 73)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM531243(US11208388, Example 74)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM531244(US11208388, Example 75)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM531245(US11208388, Example 76)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM531246(US11208388, Example 78)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM531248(US11208388, Example 86)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426702(N-(3-(6-(6-(3-fluorophenoxy)pyridin-3- yl)quinazol...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426704(N-(3-(6-(4-(pyridin-2-yloxy)phenyl)quinazolin- 8-y...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM531251(US11208388, Example 102)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426706(N-(3-(2-amino-6-(5-chloropyridin-3- yl)quinazolin-...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426707(N-(3-(6-(2-fluoro-4-((3-fluoropyridin-2- yl)oxy)ph...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426708(N-(3-(6-(4-((3-chloropyridin-2-yl)oxy)-2- fluoroph...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426709(N-(3-(2-amino-6-(5-fluoropyridin-3- yl)quinazolin-...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426710(N-(3-(6-(2-fluoro-4-(pyridin-2-yloxy)phenyl) quina...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426711(4-(8-(3-acrylamidophenyl)quinazolin-6-yl)-3- chlor...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426712(N-(3-(6-(4-(pyridin-3-yloxy)phenyl) quinazolin-8-y...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426713(4-(8-(3-acrylamidophenyl)quinazolin-6-yl)- 3-chlor...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426715(4-(8-(3-acrylamidophenyl)quinazolin-6-yl)-3- chlor...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426714(N-(3-(6-(2-methoxy-4-(pyridin-2-yloxy)phenyl) quin...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426716(4-(8-(3-acrylamidophenyl)quinazolin-6-yl)- 3-fluor...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426717(4-(8-(3-acrylamidophenyl)quinazolin-6-yl)- N-(4-cy...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426718(4-(8-(3-acrylamidophenyl)quinazolin-6-yl)- 2-fluor...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426719(N-(3-(6-(3-fluoro-4-(pyridin-2-yloxy)phenyl) quina...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426720(4-(8-(3-acrylamidophenyl)quinazolin-6-yl)-N- (4-(t...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426721(4-(8-(3-acrylamidophenyl)quinazolin-6-yl)- N-(4-cy...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426722(4-(8-(3-acrylamidophenyl)quinazolin-6-yl)-N- (4-cy...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426723(N-(3-(2-amino-6-(2-fluoro-4-(pyridin-2- yloxy)phen...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426724(N-(3-(2-amino-6-(3-fluoro-4-(pyridin-2- yloxy)phen...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426725(4-(5-(1-acryloylpyrrolidin-3-yl)pyrrolo[1,2- c]pyr...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426726(4-(8-(3-acrylamidophenyl)quinazolin-6-yl)- 2-chlor...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Neupharma

US Patent
LigandPNGBDBM426727(N-(3-(2-amino-6-(2-methoxy-4-(pyridin-2- yloxy)phe...)
Affinity DataIC50: <100nMAssay Description:To determine IC50 of a compound against a kinase, a series of concentrations of the compound were tested for the inhibition. IC50 was calculated by p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 98 total ) | Next | Last >>
Jump to: